Valuation : LataMed AI Corp.

Market Cap 83.13M 71.35M 66.97M 61.16M 115M 7.93B 116M 793M 307M 4B 312M 305M 13.25B P/E 2024
-3.63x
P/E 2025 -102x
Enterprise Value 83.52M 71.69M 67.29M 61.45M 116M 7.97B 117M 796M 309M 4.02B 314M 307M 13.31B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
19.29%
Yield 2024 *
-
Yield 2025 -
08-19 Latamed Ai Corp. Nears Completion of Mobile Healthcare Application CI
08-12 LataMed AI VE Enters Strategic Collaboration With Caracas FC to Explore AI-Powered Athletic Performance and Operational Analytics CI
08-12 LataMed AI Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-03 LataMed AI Corp. And DROGUERIAS LALA C.A. Enter Agreement To Develop AI And Automation Tools For Pharmaceutical And Laboratory Workflows CI
07-31 LataMed AI Corp. And Venezuelan Institute For Scientific Research Enter Agreement To Develop Digital Platform Supporting Access To IVIC Laboratory Services CI
07-28 LataMed AI Corp. Announces Through its Venezuelan Operating Subsidiary Enters Agreements with Colegio Claret and Colegio Roraima to Develop School-Based Digital Healthcare Initiatives CI
07-23 LataMed AI Corp. through its subsidiary LATAMEDAI VE, and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations CI
07-20 LataMed AI Corp Advances Industrial Telemedicine Initiative For Remote And Offshore Operations In Venezuela CI
07-06 LataMed AI Corp. Begins Planned Expansion into Colombia Through Initial Due Diligence and Strategic Planning CI
07-01 Latamed Ai Ve Executes Strategic Commercial Alliance with Cantv to Expand Digital Healthcare Services Across Venezuela CI
06-30 Latamed Ai Corp. and Vértice Seguros C.A. Execute Strategic Commercial Alliance to Expand Digital Healthcare and Insurance Ecosystem CI
06-24 LataMed AI Corp. And Focus Fitness C.A. Execute Strategic Commercial And Services Agreement CI
06-11 LataMed AI Corp Initiates Strategic Process to Evaluate Installment-Based Healthcare Payment Integration with Cashea Platform CI
1 week+15.00%
Current month-22.67%
1 month-14.84%
3 months+7.50%
6 months+138.95%
Current year+253.87%
1 week 0.44
Extreme 0.435
0.54
1 month 0.34
Extreme 0.335264
0.8
Current year 0.1
Extreme 0.101663
1.38
1 year 0.1
Extreme 0.101663
1.38
3 years 0.05
Extreme 0.053
135
5 years 0.05
Extreme 0.053
135
10 years 0.05
Extreme 0.053
135
Manager TitleAgeSince
Chief Executive Officer 31 17/02/2026
Director of Finance/CFO 38 31/03/2026
Director TitleAgeSince
Director/Board Member 31 17/02/2026
Change 5-day change 1-year change 3-year change Capi.($)
+4.92%+15.00%+142.16%-97.08% 83.13M
+0.26%-1.03%+63.65%+115.51% 933M
-1.28%+5.10%-4.79%+1.14% 460M
+1.85%+7.75%-21.13%-80.77% 391M
-1.09%-1.33%-3.55%+24.43% 246M
+6.54%+48.97%+1,561.18%+2,004.17% 222M
+0.60%-0.89%-20.24%-1.47% 59.33M
Average +1.01%+10.68%+245.33%+280.85% 342.2M
Weighted average by Cap. +0.73%+5.76%+169.41%+217.16%

Financials

2024 2025
Net sales - -
Net income -3.26M -2.8M -2.63M -2.4M -4.53M -311M -4.55M -31.09M -12.05M -157M -12.24M -11.98M -520M -207K -178K -167K -153K -288K -19.79M -290K -1.98M -767K -9.98M -779K -762K -33.07M
Net Debt 339K 291K 273K 250K 471K 32.37M 473K 3.24M 1.25M 16.33M 1.27M 1.25M 54.08M 395K 339K 318K 291K 548K 37.67M 551K 3.77M 1.46M 19M 1.48M 1.45M 62.94M
Logo LataMed AI Corp.
LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.
Employees
3
Date Price Change Volume
27/08/26 $0.4828 +4.92% 16,100
26/08/26 $0.4601 -4.15% 35,400
25/08/26 $0.4800 -5.88% 25,137
24/08/26 $0.5100 +6.25% 29,979
21/08/26 $0.4800 +19.97% 182,273
  1. Stock Market
  2. Stocks
  3. LMED Stock